Incidence_NN of_IN High-Level_NP Evernimicin_NP Resistance_NP in_IN Enterococcus_NP faecium_NN among_IN Food_NP Animals_NPS and_CC Humans_NP Six_NP high-level_JJ evernimicin-resistant_JJ Enterococcus_NP faecium_NN isolates_NNS were_VBD identified_VBN among_IN 304_CD avilamycin-resistant_JJ E._NP faecium_NN isolates_VBZ from_IN animals_NNS and_CC 404_CD stool_NN samples_NNS from_IN humans_NNS with_IN diarrhea_NN ._SENT All_DT four_CD animal_JJ isolates_NNS ,_, and_CC one_CD of_IN the_DT human_JJ isolates_NNS ,_, were_VBD able_JJ to_TO transfer_VB resistance_NN to_TO a_DT susceptible_JJ E._NP faecium_NN strain_NN ._SENT The_DT resulting_VBG transconjugants_NNS all_RB tested_VBD positive_JJ for_IN the_DT presence_NN of_IN emtA_NN ,_, a_DT gene_NN encoding_VBG a_DT methyltransferase_NN previously_RB linked_VBN with_IN high-level_JJ evernimicin_NN resistance_NN ._SENT The_DT four_CD transconjugants_NNS derived_VBN from_IN animal_JJ isolates_NNS all_RB carried_VBD the_DT same_JJ plasmid_NN ,_, while_IN a_DT differently_RB sized_JJ plasmid_NN was_VBD found_VBN in_IN the_DT isolate_NN from_IN humans_NNS ._SENT This_DT study_NN demonstrated_VBD a_DT low_JJ incidence_NN of_IN high-level_JJ evernimicin_NN resistance_NN mediated_VBN by_IN the_DT emtA_NN gene_NN in_IN different_JJ E._NP faecium_NN isolates_VBZ of_IN animal_NN and_CC human_JJ origin_NN ._SENT There_EX is_VBZ a_DT growing_VBG concern_NN regarding_VBG the_DT emergence_NN of_IN multiply_RB antimicrobial-resistant_JJ enterococci_NNS as_IN important_JJ nosocomial_JJ pathogens_NNS ._SENT This_DT has_VBZ increased_VBN the_DT interest_NN in_IN either_DT developing_VBG new_JJ antibiotics_NNS or_CC modifying_VBG older_JJR antibiotics_NNS with_IN activity_NN against_IN multiply_RB resistant_JJ staphylococci_NNS and_CC enterococci_NNS ._SENT One_CD of_IN these_DT agents_NNS is_VBZ evernimicin_NN ,_, an_DT oligosaccharide_NN antibiotic_NN with_IN activity_NN against_IN a_DT broad_JJ range_NN of_IN gram-positive_JJ pathogenic_JJ bacteria_NNS including_VBG glycopeptide-resistant_JJ enterococci_NNS ,_, methicillin-resistant_JJ staphylococci_NNS ,_, and_CC penicillin-resistant_JJ streptococci_NNS ._SENT Evernimicin_NP inhibits_VBZ protein_NN synthesis_NN in_IN Staphylococcus_NP aureus_NN by_IN binding_VBG with_IN high_JJ affinity_NN to_TO a_DT single_JJ site_NN on_IN the_DT 50S_JJ subunit_NN ._SENT The_DT evernimicin_NN binding_VBG site_NN overlaps_VBZ the_DT binding_JJ site_NN of_IN another_DT oligosaccharide_NN antibiotic_NN ,_, avilamycin_NN ._SENT Avilamycin_NP has_VBZ been_VBN used_VBN as_IN a_DT growth_NN promoter_NN for_IN food_NN animals_NNS in_IN the_DT European_JJ Union_NN for_IN several_JJ years_NNS ,_, and_CC as_IN a_DT consequence_NN avilamycin_NN resistance_NN has_VBZ been_VBN observed_VBN among_IN Enterococcus_NP faecium_NN isolates_VBZ from_IN broilers_NNS in_IN Denmark_NP and_CC other_JJ countries_NNS ._SENT High-level_JJ (_( >64_JJ mug/ml_NN )_) avilamycin_NN resistance_NN is_VBZ mediated_VBN by_IN mutations_NNS in_IN the_DT gene_NN encoding_VBG ribosomal_JJ protein_NN L16_NP ;_: these_DT strains_NNS also_RB exhibit_VBP low-level_JJ (_( MIC_NP ,_, 2_CD to_TO 12_CD mug/ml_NN )_) cross-resistance_NN to_TO evernimicin_NN ._SENT ._SENT Recently_RB ,_, a_DT new_JJ methyltransferase_NN ,_, which_WDT confers_VBZ high-level_JJ (_( MIC_NP ,_, >64_NN mug/ml_NN )_) evernimicin_NN resistance_NN through_IN methylation_NN of_IN 23S_JJ rRNA_NN ,_, was_VBD cloned_VBN from_IN an_DT avilamycin-resistant_JJ E._NP faecium_NN strain_NN isolated_VBN from_IN a_DT broiler_NN in_IN Denmark_NP ._SENT The_DT present_JJ study_NN was_VBD conducted_VBN to_TO determine_VB the_DT occurrence_NN of_IN high-level_JJ evernimicin_NN resistance_NN among_IN avilamycin-resistant_JJ enterococcal_JJ isolates_NNS from_IN food_NN animals_NNS and_CC humans_NNS in_IN Denmark_NP ._SENT A_DT total_NN of_IN 304_CD avilamycin-resistant_NN (_( MIC_NP ,_, >=16_NN mug/ml_NN )_) E._NP faecium_NN and_CC 14_CD Enterococcus_NP faecalis_NN isolates_NNS were_VBD obtained_VBN from_IN the_DT continuous_JJ monitoring_NN for_IN antimicrobial_JJ resistance_NN among_IN broilers_NNS and_CC pigs_NNS in_IN Denmark_NP ._SENT These_DT isolates_NNS were_VBD screened_VBN for_IN high-level_JJ (_( MIC_NP ,_, >128_NN mug/ml_NN )_) evernimicin_NN resistance_NN by_IN the_DT E-test_NN according_VBG to_TO the_DT manufacturer_NN 's_POS guidelines_NNS (_( AB_NP Biodisk_NP ,_, Solna_NP ,_, Sweden_NP )_) ;_: four_CD positive_JJ isolates_NNS were_VBD identified_VBN ._SENT In_IN March_NP 1998_CD a_DT total_NN of_IN 254_CD human_JJ stool_NN samples_NNS ,_, submitted_VBN for_IN examination_NN of_IN diarrheal_JJ pathogens_NNS ,_, were_VBD examined_VBN for_IN the_DT presence_NN of_IN avilamycin-resistant_JJ enterococci_NNS by_IN plating_VBG a_DT loopful_NN of_IN fecal_JJ material_NN on_IN Mueller-Hinton_NP II_NP agar_NN plates_NNS containing_VBG 20_CD mug_NN of_IN avilamycin/ml_NN ._SENT All_DT patients_NNS sampled_VBD had_VBD a_DT history_NN of_IN diarrhea_NN but_CC no_DT history_NN of_IN either_CC a_DT recent_JJ hospital_NN stay_NN or_CC antimicrobial_JJ treatment_NN ._SENT One_CD avilamycin-resistant_JJ E._NP faecium_NN isolate_NN was_VBD identified_VBN ;_: this_DT isolate_NN also_RB exhibited_VBN high-level_JJ evernimicin_NN resistance_NN ._SENT In_IN June_NP 2001_CD an_DT additional_JJ 150_CD fecal_JJ samples_NNS from_IN humans_NNS were_VBD ,_, in_IN relation_NN to_TO another_DT study_NN ,_, screened_VBN for_IN the_DT presence_NN of_IN enterococcal_JJ isolates_NNS resistant_JJ to_TO erythromycin_NN and_CC tetracycline_NN with_IN Slanetz_NP and_CC Bartley_NP agar_NN plates_NNS containing_VBG erythromycin_NN (_( 20_CD mug/ml_NN )_) and_CC tetracycline_NN (_( 10_CD mug/ml_NN )_) ._SENT Isolates_NNS obtained_VBN from_IN these_DT samples_NNS were_VBD also_RB screened_VBN for_IN avilamycin_NN resistance_NN ;_: one_CD isolate_NN was_VBD recovered_VBN which_WDT also_RB tested_VBD positive_JJ for_IN high-level_JJ evernimicin_NN resistance_NN ._SENT All_DT six_CD isolates_NNS tested_VBD positive_JJ in_IN PCR_NP for_IN the_DT emtA_NN gene_NN with_IN the_DT following_VBG oligonucleotides_NNS as_IN primers_NNS :_: 5'-GGTCAGCAGATCACTTGTTT-3_NP '_POS and_CC 5'-TGAACAATTCTAAGTCCTCG-3_NP '_POS ._SENT The_DT six_CD evernimicin-resistant_JJ isolates_NNS were_VBD subjected_VBN to_TO pulsed-field_JJ gel_NN electrophoresis_NN (_( PFGE_NP )_) typing_VBG with_IN the_DT restriction_NN enzyme_NN SmaI_NP ._SENT DNA_NP purification_NN and_CC enzyme_NN digestion_NN were_VBD performed_VBN as_IN previously_RB described_VBN ._SENT Four_CD different_JJ PFGE_NP types_NNS were_VBD identified_VBN :_: three_CD of_IN the_DT four_CD broiler_NN isolates_NNS belonged_VBD to_TO the_DT same_JJ PFGE_NN type_NN ,_, and_CC the_DT two_CD isolates_NNS from_IN humans_NNS gave_VBD different_JJ PFGE_NP patterns_NNS ._SENT We_PP screened_VBD all_DT six_CD isolates_NNS for_IN the_DT ability_NN to_TO transfer_VB evernimicin_NN resistance_NN to_TO E._NP faecium_NN BM4105_NP (_( resistant_JJ to_TO rifampin_NN and_CC fusidic_JJ acid_NN )_) by_IN the_DT filter_NN mating_NN procedure_NN described_VBD previously_RB ._SENT Transconjugants_NNS were_VBD isolated_VBN from_IN within_IN the_DT inhibition_NN zone_NN of_IN an_DT E-test_NN strip_NN laid_VBN down_RP on_IN Mueller-Hinton_NP II_NP agar_NN plates_NNS containing_VBG rifampin_NN (_( 50_CD mug/ml_NN )_) and_CC fusidic_JJ acid_NN (_( 10_CD mug/ml_NN )_) ._SENT All_DT four_CD animal_JJ isolates_NNS and_CC one_CD of_IN the_DT human_JJ isolates_NNS yielded_VBD transconjugants_NNS ._SENT Transconjugants_NNS were_VBD screened_VBN for_IN susceptibility_NN to_TO avilamycin_NN ,_, bacitracin_NN ,_, chloramphenicol_NN ,_, erythromycin_NN ,_, gentamicin_NN ,_, kanamycin_NN ,_, penicillin_NN ,_, streptomycin_NN ,_, quinupristin-dalfopristin_NP ,_, tetracycline_NN ,_, and_CC vancomycin_NP as_RB previously_RB described_VBN ._SENT Resistance_NN to_TO avilamycin_NN was_VBD cotransferred_JJ ,_, but_CC no_DT other_JJ drug_NN resistance_NN markers_NNS appeared_VBD to_TO be_VB cotransferred_JJ ._SENT Plasmid_NP DNA_NP was_VBD extracted_VBN from_IN the_DT five_CD transconjugants_NNS with_IN the_DT Qiagen_NP Plasmid_NP Midi_NP kit_NN (_( Qiagen_NP ,_, Valencia_NP ,_, Calif._NP )_) and_CC restricted_VBN with_IN either_DT EcoRI_NP or_CC PvuII_NP ._SENT EcoRI_NP digestion_NN of_IN the_DT plasmids_NNS from_IN the_DT four_CD broiler_NN isolates_NNS yielded_VBD three_CD different_JJ bands_NNS ,_, while_IN PvuII_NP digestion_NN yielded_VBD five_CD bands_NNS ._SENT The_DT plasmids_NNS from_IN the_DT four_CD broiler_NN isolates_NNS were_VBD approximately_RB 36_CD kb_NN and_CC indistinguishable_JJ even_RB though_IN the_DT four_CD isolates_NNS fell_VBD into_IN two_CD different_JJ PFGE_NP patterns_NNS ._SENT In_IN contrast_NN ,_, the_DT human_JJ isolate_NN harbored_VBD a_DT plasmid_NN of_IN >100_JJ kb_NN ._SENT EcoRI_NP digestion_NN yielded_VBD 22_CD bands_NNS ,_, and_CC PvuII_NP digestion_NN yielded_VBD 18_CD bands_NNS ._SENT To_TO determine_VB if_IN high-level_JJ evernimicin_NN resistance_NN was_VBD linked_VBN to_TO the_DT presence_NN of_IN the_DT emtA_NN gene_NN ,_, we_PP performed_VBD a_DT Southern_JJ blot_NN analysis_NN on_IN the_DT restricted_JJ plasmids_NNS ._SENT A_DT digoxigenin-labeled_JJ emtA_NN fragment_NN was_VBD prepared_VBN by_IN PCR_NP with_IN the_DT oligonucleotides_NNS described_VBD above_IN ._SENT The_DT emtA_NN probe_NN hybridized_VBN to_TO DNA_NN fragments_NNS of_IN approximately_RB 6.9_CD and_CC 12.5_CD kb_NN in_IN the_DT EcoRI_NP and_CC PvuII_NP restriction_NN digests_NNS ,_, respectively_RB ,_, of_IN the_DT transconjugants_NNS from_IN the_DT four_CD broiler_NN isolates_VBZ (_( data_NNS not_RB shown_VBN )_) ._SENT In_IN contrast_NN ,_, the_DT emtA_NN probe_NN hybridized_VBN to_TO fragments_NNS of_IN 3.3_CD and_CC 4.5_CD kb_NN in_IN the_DT EcoRI_NP and_CC PvuII_NP digests_NNS of_IN the_DT transconjugant_NN of_IN the_DT human_JJ isolate_NN ._SENT FIG._NN 1_CD ._SENT |_SYM PFGE_NP profile_NN of_IN six_CD high-level_JJ evernimicin-resistant_NN E._NP PFGE_NP profile_NN of_IN six_CD high-level_JJ evernimicin-resistant_JJ E._NP faecium_NN isolates_VBZ from_IN humans_NNS and_CC broilers_NNS ._SENT Lanes_NNS 1_CD and_CC 8_CD ,_, 50-kb_JJ ladder_NN ;_: lane_NN 2_CD ,_, isolate_VBP 1_CD from_IN humans_NNS ;_: lane_NN 3_CD ,_, isolate_VBP 2_CD from_IN humans_NNS ;_: lanes_NNS 4_CD to_TO 7_CD ,_, isolates_VBZ 1_CD to_TO 4_CD ,_, respectively_RB ,_, from_IN broilers_NNS ._SENT The_DT present_JJ study_NN demonstrated_VBD that_IN high-level_JJ evernimicin_NN resistance_NN has_VBZ not_RB been_VBN widely_RB disseminated_VBN among_IN E._NP faecium_NN strains_NNS isolated_VBN from_IN the_DT animal_NN or_CC human_JJ population_NN in_IN Denmark_NP ._SENT In_IN the_DT four_CD isolates_NNS from_IN broilers_NNS ,_, three_CD of_IN which_WDT appeared_VBD clonal_JJ ,_, the_DT emtA_NN gene_NN was_VBD carried_VBN by_IN a_DT similarly_RB sized_VBN plasmid_NN in_IN each_DT case_NN ._SENT In_IN contrast_NN ,_, a_DT plasmid_NN of_IN different_JJ size_NN was_VBD observed_VBN in_IN the_DT single_JJ human_JJ isolate_NN capable_JJ of_IN transferring_VBG evernimicin_NN resistance_NN ._SENT Since_IN the_DT emtA_NN gene_NN is_VBZ part_NN of_IN a_DT transposon_NN ,_, it_PP is_VBZ possible_JJ that_IN it_PP was_VBD transposed_VBN from_IN one_CD plasmid_NN to_TO a_DT different_JJ plasmid_NN ._SENT Several_JJ studies_NNS have_VBP indicated_VBN that_IN bacteria_NNS from_IN animals_NNS and_CC humans_NNS share_VBP the_DT same_JJ resistance_NN genes_NNS and_CC that_DT exchange_NN probably_RB occurs_VBZ fairly_RB frequently_RB ._SENT This_DT includes_VBZ resistance_NN genes_NNS in_IN enterococci_NNS where_WRB the_DT genes_NNS encoding_VBG resistance_NN to_TO important_JJ human_JJ antibiotics_NNS such_JJ as_IN vancomycin_NP (_( vanA_NP )_) and_CC quinupristin-dalfopristin_NNS [_SYM vat(E)_JJ and_CC erm(B)_NNS ]_SYM probably_RB have_VB spread_VBN from_IN the_DT animal_JJ reservoir_NN to_TO humans_NNS and_CC thereby_RB perhaps_RB shortened_VBN the_DT life_NN span_NN of_IN these_DT antibiotics_NNS ._SENT 